Urokinase for Injection Manufacturers PAN India, Suppliers
Leading Manufacturer and Exporter of Urokinase for Injection 500000IU (UVANTAJ)
Taj Pharma India is recognized as one of the top manufacturers, exporters, and suppliers of Urokinase for Injection 500000IU (UVANTAJ) in India. Known for its high-quality standards, purity, and reliable formulations, Taj Pharmaceuticals Ltd. has established its footprint across India, Africa, the Middle East, LATAM, and multiple international markets.
Urokinase for Injection is a life-saving thrombolytic medicine widely used for dissolving dangerous blood clots in the bloodstream. It is crucial for treating pulmonary embolism, myocardial infarction (heart attack), ischemic stroke, and other blood clot-related complications. Administered strictly under medical supervision in hospital settings, Urokinase ensures restored blood flow to critical tissues, significantly improving patient survival outcomes.
About Urokinase for Injection 500000IU (UVANTAJ)
Urokinase for Injection 500000IU is a sterile, thrombolytic agent that actively breaks down fibrin-based blood clots. The formulation by Taj Pharma India ensures premium efficacy, controlled dosing, and enhanced safety for patients requiring emergency clot-dissolving therapy.
- Generic Name: Urokinase for Injection
- Brand Name: UVANTAJ
- Strength: 500000IU per vial
- Dosage Form: Lyophilized powder for reconstitution
- Route of Administration: Intravenous (IV) under strict medical supervision
- Therapeutic Use: Dissolution of thrombi in conditions like myocardial infarction, pulmonary embolism, deep vein thrombosis, and stroke
Key Therapeutic Indications
Urokinase is a critical life-saving medicine that helps restore normal blood flow by dissolving obstructive clots. Taj Pharma India’s UVANTAJ 500000IU is widely used in the following conditions:
- Acute Myocardial Infarction (Heart Attack):
Dissolves clots in coronary arteries to prevent heart tissue damage. - Pulmonary Embolism:
Clears blood clots in pulmonary arteries, preventing lung damage and respiratory distress. - Deep Vein Thrombosis (DVT):
Reduces risk of long-term venous obstruction and pulmonary complications. - Ischemic Stroke:
Administered to restore cerebral blood flow, minimizing stroke-related disabilities. - Central Venous Catheter Clearance:
Used in hospitals to clear occluded catheters and maintain IV line functionality.
Why Choose Taj Pharma India for Urokinase Injections?
Taj Pharmaceuticals Ltd. has earned its reputation as a top Urokinase injection manufacturer due to its state-of-the-art manufacturing practices, global quality compliance, and large-scale production capacity.
1. High-Quality Formulation and Purity
- Manufactured in WHO-GMP and ISO-certified facilities.
- Complies with USFDA, EMA, and international pharmacopeial standards.
- Strict sterility and endotoxin control measures ensure safe hospital administration.
2. PAN India and Global Supply Network
- Supplies Urokinase injections to major Indian hospitals and global healthcare markets.
- Strong export presence in Africa, the Middle East, and Latin America (LATAM).
- Reliable cold-chain and temperature-controlled shipment solutions.
3. Expertise in Hospital & Emergency Medicines
- Decades of experience in critical care injectables.
- Ensures on-time availability of life-saving drugs for government tenders and private hospital chains.
Dosage and Administration Guidelines
Urokinase for Injection 500000IU should always be administered under the supervision of a qualified physician in a hospital or emergency care setting.
- Reconstitution: Dissolve lyophilized powder using the recommended diluent as per the pack insert.
- Intravenous Administration: Slowly infused under continuous monitoring of blood pressure and coagulation parameters.
- Dosage Determination: Based on patient’s weight, age, and medical condition, as assessed by the doctor.
- Monitoring:
- Bleeding risk evaluation during therapy
- Clot resolution assessment through imaging and lab parameters
Safety, Warnings, and Precautions
1. Caution in Specific Conditions
- Patients with active bleeding, recent surgery, or hemorrhagic stroke should avoid therapy unless critically indicated.
- Liver and kidney patients may require dose adjustment and close monitoring.
2. Pregnancy and Breastfeeding
- Probably safe during pregnancy, but requires doctor evaluation.
- Minimal transfer to breast milk, considered low-risk during lactation.
3. Alcohol and Drug Interactions
- Alcohol consumption is not recommended during therapy.
- Avoid concurrent use with anticoagulants without medical supervision to minimize bleeding risk.
Technical Specifications
| Parameter | Details |
|---|---|
| Product Name | Urokinase for Injection 500000IU (UVANTAJ) |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Dosage Form | Lyophilized Powder for IV Injection |
| Strength | 500000IU |
| Packing | 1 Vial with Diluent |
| Route of Administration | Intravenous |
| Therapeutic Use | Thrombolytic / Clot Dissolution |
| Storage | 2°C to 8°C, protected from light |
| Regulatory Compliance | WHO-GMP, ISO Certified, International Standards |
Global Presence and PCD Pharma Franchise Opportunities
Taj Pharma India not only caters to domestic hospitals and distributors but also actively exports Urokinase for Injection worldwide. With a strong PCD Pharma Franchise model, Taj Pharma offers:
- Monopoly distribution rights in selected territories
- Marketing and promotional support for business partners
- Assured high-quality product supply with competitive pricing
Whether you are a pharma distributor, hospital buyer, or PCD franchise partner, Taj Pharma India ensures world-class service and reliable product delivery.
📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
When it comes to high-quality Urokinase for Injection 500000IU (UVANTAJ) in India, Taj Pharma India stands as the most trusted manufacturer and exporter. With its dedicated manufacturing excellence, global regulatory compliance, and strong distribution network, Taj Pharmaceuticals ensures timely availability of life-saving Urokinase injections for critical hospital use worldwide.
